Letter to the editors on ‘Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials’

Yan Rong Li; Shang Yu Wang; Chun Nan Yeh

doi:10.1111/cen.14565

Letter to the editors on ‘Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials’

Yan Rong Li
, Shang Yu Wang
, Chun Nan Yeh^*

^*Corresponding author for this work

School of Traditional Chinese Medicine

Chang Gung Memorial Hospital
Chang Gung University

Research output: Contribution to journal › Journal Letter › peer-review

Original language	English
Pages (from-to)	133
Number of pages	1
Journal	Clinical Endocrinology
Volume	98
Issue number	1
DOIs	https://doi.org/10.1111/cen.14565
State	Published - 01 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Humans
Iodine Radioisotopes/therapeutic use
Phenylurea Compounds/therapeutic use
Treatment Outcome
Thyroid Neoplasms/drug therapy

Access to Document

10.1111/cen.14565

Cite this

@article{06e2c24dbc0c458bb10b0ef230bfcb89,

title = "Letter to the editors on {\textquoteleft}Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials{\textquoteright}",

keywords = "Humans, Iodine Radioisotopes/therapeutic use, Phenylurea Compounds/therapeutic use, Treatment Outcome, Thyroid Neoplasms/drug therapy",

author = "Li, \{Yan Rong\} and Wang, \{Shang Yu\} and Yeh, \{Chun Nan\}",

year = "2023",

month = jan,

doi = "10.1111/cen.14565",

language = "英语",

volume = "98",

pages = "133",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "1",

}

TY - JOUR

T1 - Letter to the editors on ‘Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma

T2 - A systematic review and meta-analysis of clinical trials’

AU - Li, Yan Rong

AU - Wang, Shang Yu

AU - Yeh, Chun Nan

PY - 2023/1

Y1 - 2023/1

KW - Humans

KW - Iodine Radioisotopes/therapeutic use

KW - Phenylurea Compounds/therapeutic use

KW - Treatment Outcome

KW - Thyroid Neoplasms/drug therapy

UR - https://www.scopus.com/pages/publications/85111362584

U2 - 10.1111/cen.14565

DO - 10.1111/cen.14565

M3 - 快报

C2 - 34288014

AN - SCOPUS:85111362584

SN - 0300-0664

VL - 98

SP - 133

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 1

ER -

Letter to the editors on ‘Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials’

UN SDGs

Keywords

Access to Document

Other files and links

Cite this